一个网络驱动的框架,以加强冠状动脉疾病中的基因疾病关联研究
Gutama Ibrahim Mohammad1, Johan Lm Björkegren2, Tom Michoel1
1Computational Biology Unit, Department of Informarics, University of Bergen, Norway.
ArXiv
|February 20, 2025
概括
这项研究引入了一个新的框架,将基因调节网络 (GRNs) 整合到全转录组关联研究 (TWAS) 中,以更好地了解复杂的疾病. 这种方法增强了与冠状动脉疾病 (CAD) 等疾病相关的基因和途径的发现.
科学领域:
- 遗传学 遗传学 是一个
- 系统生物学 系统生物学
- 计算生物学 计算生物学
背景情况:
- 全基因组关联研究 (GWAS) 识别复杂疾病的遗传变异,但将它们与生物机制联系起来仍然具有挑战性.
- 大多数与疾病相关的变异是非编码的,影响基因表达,但目标基因和细胞类型通常是未知的.
- 传统的全转录组关联研究 (TWAS) 可能会错过跨监管效应和全面的监管网络.
研究的目的:
- 开发一种新的框架,将cis和trans遗传调节效应集成到TWAS中,使用组织特异性基因调节网络 (GRNs).
- 通过弥合遗传变异和基因表达之间的差距,提高对复杂疾病背后的分子机制的理解.
- 识别与复杂疾病相关的新药标和途径.
主要方法:
- 利用组织特异性基因调控网络 (GRNs) 来增强TWAS框架.
- 在新分析方法中整合 cis 和 trans 基因调节效应.
- 使用来自STARNET项目的冠状动脉疾病 (CAD) 数据验证框架.
主要成果:
- 该GRN驱动的框架显示了发现更多与冠状动脉疾病 (CAD) 相关的基因和途径的潜力.
- 初步结果表明,与传统的TWAS相比,与疾病相关的遗传调节效应的识别得到了改进.
- 该方法通过结合全面的监管见解,促进了对复杂疾病遗传架构的理解.
结论:
- 新的GRN增强的TWAS框架为研究复杂疾病提供了更全面的方法.
- 这种方法有助于发现新的与疾病相关的基因和途径,特别是在CAD等疾病中.
- 该框架代表了将生物发现的遗传和监管信息整合起来的一个重大进步.
更多相关视频
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
12.9K
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
3.5K
相关概念视频
01:11Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
01:05Single Nucleotide Polymorphisms-SNPs
13.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.9K